Application no. and date | 06749882.4 (espacenet) (Federated) (European Patent Register), 20060411 | Patent/reg. no. and date | DK/EP 1869011, 20120801 | Publication date | 20071226 | Priority no. and date | US 670204 P, 20050411 | EP pub. no. and date |
EP 1869011 20071226 | Effective date | | Applicant/owner | AbbVie Ireland Unlimited Company, 70 Sir John Rogerson's Quay
Dublin 2
Dublin, D02 R296
, IE | Applicant ref. no. | P009764EPDK1 | Inventor | GONG, Jianchun, 130 Ferndale Rd
Deerfield, IL 60015, US, ZHU, Guidong, 1395 Almaden Ln
Gurnee, IL 60031, US, PENNING, Thomas, D., 321 Highview
Elmhurst, IL 60126, US, GIRANDA, Vincent, 272 S Fork Dr
Gurnee, IL 60031, US, GANDHI, Virajkumar, B., 5335 Mahogany Ct.
Gurnee, IL 60031, US | Representative | CHAS. HUDE A/S, Langebrogade 3B, 1411 København K, DK | Opponent | | IPC Class | A61K 31/4184 (2006.01) , A61K 31/454 (2006.01) , C07D 401/04 (2006.01) , C07D 403/04 (2006.01) | Title | 1H-benzimidazol-4-carboxamider substitueret med et kvaternært carbon i 2-stillingen er potente PARP-inhibitorer | Int. application no. | US2006013652 | Int. publication no. | WO2006110816 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|